Leaflet Modification and Septal Reduction in Bioprosthetic Mitral Intervention (When and Why)

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; Edwards Lifesciences; Boston Scientific Corporation; Abbott
• Royalty/Intellectual Property Rights - National Institutes of Health